Daily Archives: October 6, 2020

It’s OK for Physicians Not to Go by the Book

Some time ago, I performed a colonoscopy on a patient who was having serious internal bleeding. He had already received multiple transfusions since he was admitted to the hospital. After obtaining informed consent for the procedure, I performed the colon exam. I encountered blood throughout the entire colon, but saw no definite bleeding site, raising the possibility that the source …

Read More »

‘Abuse Deterrent’ ADHD Tx May Face Uphill Approval Path

An abuse-deterrent stimulant product for attention deficit-hyperactivity disorder (ADHD) got a skeptical review from FDA technical staff ahead of an advisory committee meeting later this week. AR19 is an oral amphetamine sulfate immediate-release capsule formulated to reduce non-oral abuse. The drug, developed by Arbor Pharmaceuticals, will go before the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk …

Read More »

82% of Hospitalized COVID-19 Patients Had Neurologic Symptoms

More than 80% of hospitalized COVID-19 patients had neurologic symptoms during their disease course, a retrospective Chicago-area study showed. Neurologic manifestations were present at COVID-19 onset in 42.2% of 509 consecutive hospitalized COVID-19 patients, at hospitalization in 62.7%, and at anytime during the disease course in 82.3%, reported Igor Koralnik, MD, of Northwestern Medicine in Chicago, and colleagues in the …

Read More »

Here’s What to Know About Trump’s Experimental COVID-19 Treatment

Share on PinterestPresident Trump has been at Walter Reed Medical since Friday. Getty Images After testing positive for COVID-19, the president was given an experimental antibody drug along with several other treatments. The president’s age, weight, and gender put him at a higher risk of severe illness from COVID-19. He’s taking both experimental treatments and a common steroid. On Friday, …

Read More »

Higher PPI Doses Tied to Gastrointestinal Metaplasia Risk in H. Pylori-Positive Patients

(MedPage Today) — Study Authors: Yifat Snir, Haim Leibovitzh, et al. Target Audience and Goal Statement: Gastroenterologists, oncologists, infectious disease specialists The goal of this study was to evaluate whether cumulative proton pump inhibitor… Source link : https://www.medpagetoday.org/gastroenterology/pepticulcerdisease/88976 Author : Publish date : 2020-10-06 12:00:00 Copyright for syndicated content belongs to the linked Source.

Read More »

Chronic, Preventive Care Fell as Telemedicine Soared During COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. As the COVID-19 pandemic drove down the number of primary care visits and altered the method — moving many to telehealth appointments instead of in-person visits — the content of those appointments also changed, researchers report in JAMA Network Open. Specifically, researchers found that preventive and …

Read More »